TANG PRIZE/Tang Prize honors scientists for work to combat diabetes, obesity
06/19/2024 05:17 PM
Three scientists were awarded the 2024 Tang Prize in Biopharmaceutical Science for discovering the Glucagon-like peptide-1 (7-37) (GLP-1 (7-37)) stimulates insulin secretion and can be used in medication combating diabetes and obesity, the Tang Prize Selection Committee announced Wednesday in Taipei.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM
- Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM
- Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Society
Prosecutors investigate manslaughter in deadly Taichung explosion
02/14/2025 10:20 PM - Cross-Strait
Taiwan reaffirms sailor's citizenship after self-reporting Chinese ID card
02/14/2025 09:30 PM - Society
Toddler undergoes brain surgery after Taichung mall explosion
02/14/2025 08:43 PM - Cross-Strait
Supreme Court upholds High Court decision in military espionage case
02/14/2025 08:42 PM - Politics
Taiwan to boost U.S. investments amid Trump's tariff threats: Lai
02/14/2025 07:08 PM